SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001193125-23-270796
Filing Date
2023-11-06
Accepted
2023-11-06 06:07:31
Documents
15
Period of Report
2023-09-08
Items
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K/A d574677d8ka.htm   iXBRL 8-K/A 28751
2 EX-23.1 d574677dex231.htm EX-23.1 1787
3 EX-99.1 d574677dex991.htm EX-99.1 557704
4 EX-99.2 d574677dex992.htm EX-99.2 202916
  Complete submission text file 0001193125-23-270796.txt   1018817

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA chrs-20230908.xsd EX-101.SCH 2850
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE chrs-20230908_lab.xml EX-101.LAB 18701
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE chrs-20230908_pre.xml EX-101.PRE 11695
9 EXTRACTED XBRL INSTANCE DOCUMENT d574677d8ka_htm.xml XML 4962
Mailing Address C/O DENNIS M. LANFEAR 333 TWIN DOLPHIN DR, SUITE 600 REDWOOD CITY CA 94065
Business Address C/O DENNIS M. LANFEAR 333 TWIN DOLPHIN DR, SUITE 600 REDWOOD CITY CA 94065 (650) 649-3530
Coherus BioSciences, Inc. (Filer) CIK: 0001512762 (see all company filings)

IRS No.: 273615821 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-36721 | Film No.: 231377999
SIC: 2836 Biological Products, (No Diagnostic Substances)